Harshbarger, Diana [R-TN-1]
Republican · TN · 23 bills sponsored
Michael Enzi Voluntary Protection Program Act of 2025
# Michael Enzi Voluntary Protection Program Act of 2025 (HR 2844) **What the Bill Does** This bill would expand and modify the Voluntary Protection Program (VPP), an existing Department of Labor initiative that recognizes employers who demonstrate exemplary workplace safety practices. The bill is named after former Senator Michael Enzi of Wyoming. While the specific provisions aren't detailed in the summary provided, the bill focuses on administrative procedures and regulatory changes related to how this safety program operates. **Who It Affects** The bill primarily affects employers who participate in or wish to join the VPP, as well as their workers. The Department of Labor would also be impacted as the agency responsible for administering the program. In general, any business interested in achieving recognition for strong safety records could be affected by changes to the program's requirements or processes. **Current Status** As of now, HR 2844 is in committee, meaning it has been referred to the appropriate House committee for review and discussion but has not yet been voted on by the full House of Representatives. The bill was introduced by Representative Diana Harshbarger (R-TN).
ADAS Functionality and Integrity Act
# ADAS Functionality and Integrity Act (HR 6688) Summary **What the Bill Would Do:** This bill would establish federal standards and requirements for Advanced Driver Assistance Systems (ADAS)—the semi-autonomous safety features found in modern vehicles like lane-keeping assist, automatic braking, and adaptive cruise control. The legislation would set minimum performance standards, require manufacturers to disclose how these systems work, and establish testing protocols to ensure they function safely and reliably across different driving conditions. **Who It Affects:** The bill primarily impacts automobile manufacturers, vehicle owners, and drivers. Manufacturers would need to meet new federal requirements when designing and selling vehicles with ADAS features. Consumers would benefit from clearer information about what these systems can and cannot do, potentially reducing misuse and accidents caused by driver misunderstanding. **Current Status:** The bill is currently in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. No specific provisions or voting timeline have been announced. The bill reflects growing congressional concern about ensuring safety standards as increasingly automated vehicle technology becomes common on American roads.
Immediate Access for the Terminally Ill Act
# Immediate Access for the Terminally Ill Act (HR 7104) — Summary **What the Bill Does:** This bill would allow terminally ill patients to access experimental drugs and treatments that haven't yet been approved by the FDA. Currently, patients with terminal illnesses can petition the FDA for access to experimental medications through a process called "compassionate use," but this bill appears designed to streamline or expand that access pathway. The exact provisions aren't detailed in the summary, but the bill's intent is to make it faster or easier for dying patients to try treatments that might help them when standard options have been exhausted. **Who It Affects:** The bill primarily affects terminally ill patients and their families who are seeking alternative treatment options. It could also impact pharmaceutical companies developing experimental drugs, and the FDA, which would need to process requests under any new procedures established by the law. **Current Status:** As of now, HR 7104 is in committee, meaning it's under review and has not yet been voted on by the full House of Representatives. The bill was introduced by Representative Diana Harshbarger (R-TN). *Note: Full legislative language wasn't available to review specific provisions—for complete details, consult Congress.gov.*
DRIVER Act
# DRIVER Act Summary I don't have access to the specific details of HR 6687 (the DRIVER Act) from the 119th Congress, so I can't provide you with accurate information about what this bill specifically does, who it affects, or its key provisions. To get a reliable summary, I'd recommend: - **Congress.gov**: Search for "HR 6687" to see the bill text, summary, and sponsor details - **Your representative's website**: Often includes explanations of bills they sponsor - **Nonpartisan sources**: Organizations like the Congressional Research Service provide objective summaries If you can share the bill's text or a link to it, I'd be happy to help summarize it for you in plain language.
DSH in Tennessee Act
# DSH in Tennessee Act Summary **What the Bill Would Do:** The DSH in Tennessee Act (HR 6393) would address Disproportionate Share Hospital (DSH) payments in Tennessee. DSH payments are federal Medicaid funds distributed to hospitals that serve a large share of low-income and uninsured patients. This bill would likely modify how Tennessee hospitals receive these federal funds, though specific details aren't publicly available in the basic bill information. **Who It Affects:** The legislation would primarily impact Tennessee hospitals, particularly those serving significant numbers of Medicaid patients and uninsured individuals. It could also affect patients who rely on these hospitals for care and the state's healthcare system more broadly. **Current Status:** The bill is currently in committee, meaning it has been introduced but has not yet advanced to a full vote in the House of Representatives. As of now, it remains in the early stages of the legislative process. *Note: More detailed information about specific provisions would require access to the full bill text, which appears to have limited public documentation at this stage.*
ROOT Act
# ROOT Act Summary I don't have access to the specific details of HR 5737 (the ROOT Act) from the 119th Congress in my training data, so I cannot provide you with accurate information about what this bill would do, who it affects, or its key provisions. To get reliable information about this bill, I'd recommend: - **Congress.gov** - The official legislative database where you can search bills by number and see full text, summaries, and status - **Your representative's website** - Often includes information about bills they sponsor - **Nonpartisan sources** like the Congressional Research Service or major news outlets covering legislation If you can share the bill's text or summary, I'd be happy to help you understand it in plain language.
Drug Shortage Compounding Patient Access Act of 2025
# Drug Shortage Compounding Patient Access Act of 2025 (HR 5316) - Summary **What the Bill Would Do:** This bill aims to address drug shortages by allowing pharmacies to compound (prepare) certain medications when the FDA-approved versions are unavailable. Compounding is when pharmacists mix ingredients to create custom medications, typically in their own pharmacies. The bill would expand when and how pharmacies can legally do this during drug shortage situations, potentially giving patients access to needed medications that aren't otherwise available through normal supply chains. **Who It Affects:** The bill would primarily impact patients who need medications that are experiencing shortages, pharmacies and pharmacists who would gain expanded authority to compound drugs, and pharmaceutical manufacturers. It could also affect the FDA, which oversees drug safety and would need to implement any new regulations. **Current Status:** As of now, HR 5316 is in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. The bill was sponsored by Representative Diana Harshbarger (R-TN). Without additional action, the bill remains in early stages of the legislative process.
5G UPGRADE Act of 2025
# 5G UPGRADE Act of 2025 Summary The 5G UPGRADE Act of 2025 (HR 5266) is a bill introduced in the House of Representatives that would support the deployment and improvement of 5G wireless networks across the United States. While the bill's full details aren't available in the provided information, bills with similar titles typically aim to streamline regulations, increase funding, or remove obstacles that slow down 5G infrastructure development. This could include measures like expediting permit approvals for cell towers, encouraging private investment in rural areas, or coordinating between federal agencies. The bill would primarily affect telecommunications companies that build and operate 5G networks, as well as consumers and businesses that rely on wireless connectivity. Rural communities might see particular benefits if the bill includes provisions to expand 5G access beyond major cities. The legislation is currently in committee, meaning it has been assigned to the appropriate House committee for review and discussion but has not yet been voted on by the full House. **Note:** Specific provisions and details are not available in the summary provided. For a complete understanding of what the bill contains, you would need to review the full text on Congress.gov.
Prescription Information Modernization Act of 2025
# Prescription Information Modernization Act of 2025 (HR 4132) Summary **What the Bill Would Do:** This bill aims to modernize how prescription information is collected, stored, and shared among healthcare providers and pharmacies. While specific details aren't provided in the available information, bills with this title typically focus on updating outdated systems that track prescription data to improve coordination between doctors and pharmacists and reduce prescription errors or duplicate medications. **Who It Affects:** The bill would primarily affect patients, healthcare providers (doctors and hospitals), pharmacies, and insurance companies. Patients could benefit from better coordination of their medications, while providers and pharmacists would have access to more current prescription records across different healthcare systems. **Current Status:** As of now, HR 4132 is in committee review, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. The bill was sponsored by Rep. Diana Harshbarger (R-TN). Without additional legislative details available, the specific provisions—such as privacy protections, funding, or implementation timelines—cannot be confirmed at this time. *Note: For the most current information and specific provisions, check Congress.gov.*
RESTORE Act
# RESTORE Act Summary I don't have access to the detailed text or specific provisions of HR 3589 (the RESTORE Act) from the 119th Congress. To provide you with an accurate summary of what this bill would do, who it affects, and its key provisions, I would need to review the actual bill text. **What I can tell you:** - It's a House bill sponsored by Rep. Diana Harshbarger (R-TN) - It's currently in committee, meaning it hasn't been debated or voted on by the full House yet - The generic title "RESTORE Act" doesn't indicate its subject matter without seeing the full details **To get accurate information, I'd recommend:** - Visiting Congress.gov and searching "HR 3589" to read the full bill text - Checking the bill's summary section, which explains its purpose - Looking at the sponsor's website or press releases for their explanation of the bill's goals If you can share the bill's summary or key provisions, I'm happy to explain them in plain language!
Pregnancy.Gov Act
# Pregnancy.Gov Act Summary **What the Bill Would Do** The Pregnancy.Gov Act would establish a dedicated federal website to provide pregnant individuals with information and resources about pregnancy, childbirth, and related health topics. The bill aims to create a centralized, government-maintained online platform where pregnant people can access medical guidance, support services, and educational materials. **Who It Affects** This legislation would primarily affect pregnant individuals seeking reliable health information. It could also impact healthcare providers, state and local governments that oversee pregnancy-related programs, and various organizations that currently provide pregnancy resources. **Current Status** As of now, HR 3287 is in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. The bill was sponsored by Representative Diana Harshbarger (R-TN). *Note: Limited details are publicly available about specific provisions of this bill. For complete information on what resources would be included or how the website would operate, you would need to review the full bill text through Congress.gov.*
Universal Savings Account Act of 2025
# Universal Savings Account Act of 2025 - Summary **What the Bill Would Do:** The Universal Savings Account Act of 2025 would create a new type of savings account that allows Americans to set aside money with tax advantages. Based on its title and the universal savings account concept, this account would likely let people contribute money that grows without being taxed, similar to existing retirement savings accounts like IRAs or 401(k)s, but potentially with fewer restrictions on when and how the money can be used. **Who It Affects:** This bill would primarily affect individual savers and potentially workers seeking more flexible ways to save money. It could also impact banks and financial institutions that would offer these accounts, as well as federal tax revenues if the accounts result in reduced tax collection. **Current Status:** The bill was introduced by Representative Diana Harshbarger (R-TN) in the 119th Congress and is currently in committee, meaning it has not yet been debated or voted on by the full House. The bill has not advanced to the next stage of the legislative process. *Note: Detailed provisions are not publicly available yet, so this summary reflects general understanding of universal savings account proposals. For specific details, refer to the full bill text on Congress.gov.*
Seniors’ Access to Critical Medications Act of 2025
# Seniors' Access to Critical Medications Act of 2025 (HR 2484) **What the Bill Would Do** This bill aims to improve Medicare beneficiaries' access to prescription medications. While the specific provisions aren't detailed in the summary provided, the bill's focus areas include congressional oversight of medication access, health personnel practices, and prescription drug policies within Medicare. The bill appears to address potential barriers that seniors face in obtaining needed medications. **Who It Affects** The primary beneficiaries would be seniors enrolled in Medicare, as well as the healthcare providers, pharmacies, and government agencies involved in the prescription drug system. The bill could also impact drug manufacturers and insurers who work within Medicare programs. **Current Status** As of now, HR 2484 is in committee, meaning it has been referred to the appropriate House committee for review and discussion but has not yet been brought to a full House vote. Bills at this stage may be revised, debated, or held without further action. To learn more about the specific provisions and any recent updates, you can check Congress.gov, which provides full bill text and legislative history.
American Music Tourism Act of 2025
# American Music Tourism Act of 2025 - Summary **What It Does:** The American Music Tourism Act would direct the National Travel and Tourism Office (a government agency within the Department of Commerce) to actively promote music-related tourism in the United States. This includes promoting U.S. music festivals, concert venues, and other music attractions to both domestic and international travelers. The bill also expands the agency's existing role in promoting sports events to include international visitors. The agency would be required to report back to Congress on these promotional efforts within one year, and then every two years afterward. **Who It Affects:** This bill primarily affects the tourism industry, music venues, and music festivals across the country, which could see increased visitor interest and economic benefits. International travelers interested in American music and sports may also benefit from enhanced promotional efforts. The National Travel and Tourism Office would need to allocate resources to these new duties. **Current Status:** The bill has passed the House of Representatives and is awaiting further action in the Senate.
MAIN Event Ticketing Act
# MAIN Event Ticketing Act Summary **What the Bill Would Do:** The MAIN Event Ticketing Act aims to regulate how tickets are sold for concerts, sports events, and other live entertainment. While specific details aren't fully available in the basic information provided, bills with this title typically target practices like hidden fees, bot-driven bulk purchases, and resale market manipulation. The legislation would likely establish clearer rules for ticketing companies and resellers to make pricing more transparent and fair for consumers buying tickets directly. **Who It Affects:** This bill would impact ticket buyers attending live events, ticketing companies like Ticketmaster, secondary ticket resellers, and event venues. Consumers would potentially benefit from clearer upfront pricing and better access to tickets. Ticketing platforms and resellers would face new compliance requirements and restrictions on their business practices. **Current Status:** The bill is currently in committee (a preliminary stage in the legislative process), meaning it's still being reviewed and debated before any floor vote. It has not yet advanced to a full House vote. *Note: For complete details on specific provisions, you may want to review the full bill text on Congress.gov, as the summary information provided was limited.*
FAIR Act
# FAIR Act Summary I appreciate you asking me to summarize this bill, but I'm unable to provide the detailed summary you've requested because the information provided is incomplete. The bill details show: - **Basic Info:** HR 2314, sponsored by Rep. Diana Harshbarger (R-TN), currently in committee - **Missing Details:** The actual text, provisions, and what the bill would do are not included in your submission To give you an accurate, factual summary covering what the bill does, who it affects, and key provisions, I would need access to the bill's actual text or a more complete legislative summary. **What you could do:** Visit Congress.gov and search for "HR 2314" to find the full bill text, summary, and any explanatory materials that would allow for a proper plain-language breakdown. If you can provide more details about the bill's content, I'd be happy to summarize it clearly for a general audience.
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.
# HR 2300 Summary **What the Bill Does** HR 2300 aims to create uniform national standards for preterm infant formula—specialized nutritional products designed for babies born prematurely. Rather than allowing each state to set its own rules, this bill would establish consistent requirements across the country. This could affect how these formulas are manufactured, labeled, tested, and distributed nationwide. **Who It Affects** The bill primarily impacts families with premature infants, healthcare providers, hospitals, and infant formula manufacturers. Parents and doctors who use preterm formulas would benefit from standardized safety and quality standards, while formula companies would operate under one set of federal rules instead of navigating different state regulations. **Current Status** The bill is currently in committee, meaning it's in the early stages of the legislative process. It was introduced by Representative Diana Harshbarger (R-TN) and has not yet been debated or voted on by the full House. The specific details about which standards would be required are not provided in this summary, so the exact provisions would need to be reviewed in the full bill text.
United States-Abraham Accords Cooperation and Security Act of 2025
# United States-Abraham Accords Cooperation and Security Act of 2025 **What the Bill Would Do** This bill aims to strengthen U.S. cooperation and security arrangements related to the Abraham Accords, a diplomatic agreement that normalized relations between Israel and several Arab nations (UAE and Bahrain) starting in 2020. The specific provisions of the bill are not detailed in the available summary, but legislation of this type typically authorizes funding, establishes cooperation frameworks, or implements security commitments between the participating countries. **Who It Affects** The bill would primarily affect U.S. foreign policy toward the Middle East and the participating nations—Israel, the United Arab Emirates, and Bahrain. It could impact defense contractors, diplomatic personnel, and international trade. Americans may see effects through U.S. military aid allocation, defense spending, or diplomatic initiatives. **Current Status** As of now, HR 1794 is in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. The bill was sponsored by Rep. Diana Harshbarger (R-TN). For more detailed information about specific provisions, interested parties would need to review the bill's full text through Congress.gov.
One Flag for All Act
# One Flag for All Act Summary **What the Bill Would Do:** The One Flag for All Act would require that only the U.S. flag be displayed on federal government buildings and military facilities. Based on its title and subject matter, the bill appears aimed at establishing a uniform flag policy across all federal properties, though the specific details of what flags it would prohibit are not provided in the available information. **Who It Affects:** This legislation would primarily impact federal agencies and the military, as it sets requirements for how federal buildings and military facilities display flags. It could also affect federal employees and visitors to these properties. **Current Status:** The bill is currently in committee (HR 1313, 119th Congress), meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. It was sponsored by Representative Diana Harshbarger (R-TN). *Note: For complete details about specific provisions, you may want to review the full bill text on Congress.gov.*
Rural Physician Workforce Production Act of 2025
# Rural Physician Workforce Production Act of 2025 – Summary **What the Bill Does:** This bill would increase Medicare payments to certain hospitals that train doctors (medical residents) in rural areas. Hospitals could receive extra payments if residents spend at least 8 weeks training in rural locations, or if a residency program conducts at least 50% of its training in rural areas. The additional payments would cover the difference between what hospitals currently receive and what they're eligible for under the new rules. **Who It Affects:** The bill targets rural and smaller hospitals—including critical access hospitals, sole community hospitals, and rural emergency hospitals—as well as the medical residents they train. Indirectly, it could affect rural communities by encouraging more doctors to train and potentially practice in underserved areas. **Key Provision:** The main incentive is financial: hospitals get extra Medicare reimbursement when they invest in rural medical training, which aims to address the shortage of physicians in rural America. **Current Status:** The bill is in committee (HR 1153, 119th Congress), meaning it hasn't yet been debated or voted on by the full House of Representatives. It was introduced by Representative Diana Harshbarger (R-TN).
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA)".
# Summary of H.J. Res. 34 **What the Bill Does:** This bill would overturn a recent Environmental Protection Agency (EPA) rule that bans trichloroethylene (TCE), a chemical used in various industrial and commercial applications. If passed, the ban would be nullified, allowing TCE to continue being manufactured, imported, and used in the United States. The EPA issued this rule in December 2024 under the Toxic Substances Control Act, determining that TCE poses significant health risks. **Who It Affects and Key Details:** The bill would primarily affect manufacturers, importers, and businesses that use TCE in their operations, as well as workers and communities exposed to the chemical. TCE is used in industrial cleaning, metal degreasing, and other manufacturing processes. The EPA's ban was based on health concerns associated with TCE exposure. The bill uses a congressional "disapproval" process that allows Congress to reject federal agency rules. **Current Status:** H.J. Res. 34 was introduced by Representative Diana Harshbarger (R-TN) and is currently in committee, meaning it has not yet been voted on by the full House of Representatives.
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
# HR 679 Summary **What the bill would do:** This bill would reverse FDA changes made in January 2023 that relaxed how the abortion pill mifepristone can be dispensed to patients. Specifically, it would reinstate an in-person dispensing requirement, meaning patients would need to pick up the medication directly from a clinic, medical office, or hospital rather than receiving it by mail from a pharmacy. **Who it affects:** The bill would impact patients seeking medication abortion (which uses mifepristone to end pregnancies up to 10 weeks), healthcare providers who prescribe or dispense the drug, and mail-order pharmacies currently permitted to distribute it. **Key context:** The FDA originally required in-person dispensing for safety monitoring. During COVID-19, this requirement was temporarily suspended, allowing mail delivery. In 2023, the FDA permanently removed the in-person requirement, making mifepristone more accessible by mail. This bill seeks to reverse that decision and restore the in-person requirement. **Current status:** The bill is currently in committee and has not yet advanced further in the legislative process.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA)".
# Summary of H.J. Res. 27 **What the bill would do:** This bill would overturn an EPA regulation that bans trichloroethylene (TCE), a industrial chemical, from being made, imported, or used in the United States. The EPA issued this ban in December 2024, citing health and safety concerns. If passed, this resolution would eliminate that ban and allow TCE to continue being manufactured and used. **Who it affects:** The ban primarily affects companies that manufacture or use TCE in industrial and commercial settings. TCE is used in various manufacturing processes, but the EPA restricted it due to health risks. Workers, manufacturers, and potentially consumers could be affected depending on how the chemical is used in products or production. **Current status:** The bill was introduced by Representative Diana Harshbarger (R-TN) and is currently in committee, meaning it has not yet been debated or voted on by the full House. Under congressional rules, lawmakers can use this type of resolution to disapprove of executive agency regulations they believe are problematic.